Invention Grant
- Patent Title: Nasal administration
-
Application No.: US14315132Application Date: 2014-06-25
-
Publication No.: US11554229B2Publication Date: 2023-01-17
- Inventor: Per Gisle Djupesland , Ramy A. Mahmoud , John Messina
- Applicant: OPTINOSE AS
- Applicant Address: NO Oslo
- Assignee: OPTINOSE AS
- Current Assignee: OPTINOSE AS
- Current Assignee Address: NO Oslo
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61M15/08
- IPC: A61M15/08 ; A61M16/00 ; A61M16/14 ; A61M16/20 ; A61M15/00 ; A61M11/00 ; A61M16/10

Abstract:
A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
Public/Granted literature
- US20150144129A1 NASAL ADMINISTRATION Public/Granted day:2015-05-28
Information query